Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-08-13 09:06 am Purchase | 13G | MEIRAGTX HLDGS PLC MGTX | Sanofi SNY | 12,197,737 15.8% | 7,500,000 (+159.65%) | View |
| 2024-05-31 4:30 pm Purchase | 13G | Inhibrx Biosciences Inc. INBX | Sanofi SNY | 1,157,926 8% | 1,157,926 (New Position) | View |
| 2024-02-14 3:57 pm Purchase | 13G | SANOFI-ADR SNY | Amundi | 63,625,777 5% | 63,625,777 (New Position) | View |
| 2024-02-13 1:55 pm Sale | 13G | SANOFI-ADR SNY | DODGE & COX | 78,250,193 4.9% | -5,938,881 (-7.05%) | View |
| 2024-02-06 3:14 pm Sale | 13G | SANOFI-ADR SNY | BlackRock Inc. BLK | 90,493,241 7.2% | -1,201,819 (-1.31%) | View |
| 2023-11-06 07:50 am Purchase | 13G | MEIRAGTX HLDGS PLC MGTX | Sanofi SNY | 4,697,737 7.4% | 4,697,737 (New Position) | View |
| 2023-02-14 2:22 pm Sale | 13G | SANOFI-ADR SNY | DODGE & COX | 84,189,074 5.3% | -9,212,975 (-9.86%) | View |
| 2023-02-10 4:49 pm Sale | 13G | SANOFI-ADR SNY | Amundi | 65,432,736 5.2% | -5,928,109 (-8.31%) | View |
| 2023-02-07 2:10 pm Sale | 13G | SANOFI-ADR SNY | BlackRock Inc. BLK | 91,695,060 7.2% | -1,389,360 (-1.49%) | View |
| 2022-02-22 12:04 pm Purchase | 13G | SANOFI-ADR SNY | Amundi | 71,360,845 5.7% | 23,797,608 (+50.03%) | View |
| 2022-02-15 08:17 am Sale | 13G | SANOFI-ADR SNY | Amundi | 47,563,237 3.8% | -15,754,906 (-24.88%) | View |
| 2022-02-14 1:29 pm Purchase | 13G | SANOFI-ADR SNY | DODGE & COX | 93,402,049 5.6% | 93,402,049 (New Position) | View |
| 2022-02-08 08:27 am Purchase | 13G | Icosavax Inc. ICVX | Sanofi SNY | 3,155,169 8.08% | 3,155,169 (New Position) | View |
| 2022-02-03 4:29 pm Sale | 13G | SANOFI-ADR SNY | BlackRock Inc. BLK | 93,084,420 7.4% | -767,112 (-0.82%) | View |
| 2021-08-12 4:00 pm Sale | 13D | Translate Bio Inc. TBIO | Sanofi SNY | 3,684,434 4.9% | -1,200,000 (-24.57%) | View |
| 2021-03-31 11:19 am Purchase | 13G | LAVA THERAPEUTICS N V SHS LVTX | Sanofi SNY | 1,919,455 7% | 1,919,455 (New Position) | View |
| 2021-02-16 4:33 pm Purchase | 13G | SANOFI-ADR SNY | Amundi | 63,318,143 5% | 63,318,143 (New Position) | View |
| 2021-02-11 10:46 am Purchase | 13G | Revolution Medicines Inc. RVMD | Sanofi SNY | 3,363,050 4.6% | 3,363,050 (New Position) | View |
| 2021-02-04 06:57 am Purchase | 13G | Translate Bio Inc. TBIO | Sanofi SNY | 4,884,434 6.6% | 4,884,434 (New Position) | View |
| 2021-02-01 08:17 am Purchase | 13G | SANOFI-ADR SNY | BlackRock Inc. BLK | 93,851,532 7.5% | 11,949,247 (+14.59%) | View |